These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8787955)

  • 1. The influence of chronic administration of the serotonin agonist dexfenfluramine on responsiveness to corticotropin releasing hormone and growth hormone-releasing hormone in moderately obese people.
    Drent ML; Adèr HJ; van der Veen EA
    J Endocrinol Invest; 1995 Nov; 18(10):780-8. PubMed ID: 8787955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic-pituitary-adrenal axis in abdominal obesity: effects of dexfenfluramine.
    Boushaki FZ; Rasio E; Serri O
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):461-6. PubMed ID: 9196609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific stimulation of brain serotonin mediated neurotransmission by dexfenfluramine does not restore growth hormone responsiveness in obese women.
    Kars ME; Pijl H; Cohen AF; Frölich M; Schoemaker HC; Brandenburg HC; Meinders AE
    Clin Endocrinol (Oxf); 1996 May; 44(5):541-6. PubMed ID: 8762730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man.
    Barbarino A; Corsello SM; Della Casa S; Tofani A; Sciuto R; Rota CA; Bollanti L; Barini A
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1368-74. PubMed ID: 2229294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blunted growth hormone (GH) responsiveness to GH-releasing hormone in obese patients: influence of prolonged administration of the serotoninergic drug fenfluramine.
    Argenio GF; Bernini GP; Sgró M; Vivaldi MS; Del Corso C; Santoni R; Franchi F
    Metabolism; 1991 Jul; 40(7):724-7. PubMed ID: 1870427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin hypoglycemia test and releasing hormone (corticotropin-releasing hormone and growth hormone-releasing hormone) stimulation in patients with pituitary failure of different origin.
    Stalla GK; Losa M; Oeckler R; Müller OA; von Werder K
    Horm Res; 1988; 29(5-6):191-6. PubMed ID: 2851521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyporesponsiveness of the pituitary to CRH during slow wave sleep is not mimicked by systemic GHRH.
    Antonijevic IA; Murck H; Frieboes R; Holsboer TT; Steiger A
    Neuroendocrinology; 1999 Feb; 69(2):88-96. PubMed ID: 9986921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of corticotropin and growth hormone releasing hormones on their respective secretory axes in chronic hemodialysis patients before and after correction of anemia with recombinant human erythropoietin.
    Ramirez G; Bittle PA; Sanders H; Rabb HA; Bercu BB
    J Clin Endocrinol Metab; 1994 Jan; 78(1):63-9. PubMed ID: 8288716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotoninergic receptor activation by dextrofenfluramine enhances the blunted pituitary-adrenal responsiveness to corticotropin-releasing hormone in obese subjects.
    Bernini GP; Argenio GF; Del Corso C; Vivaldi MS; Birindelli R; Franchi F
    Metabolism; 1992 Jan; 41(1):17-21. PubMed ID: 1311402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone-releasing hormone facilitates hypoglycemia-induced release of cortisol.
    Perras B; Schultes B; Schwaiger R; Metz C; Wesseler W; Born J; Fehm HL
    Regul Pept; 2002 Dec; 110(1):85-91. PubMed ID: 12468113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine responses to growth hormone-releasing hormone, thyrotropin-releasing hormone and corticotropin-releasing hormone in depression.
    Lesch KP; Müller U; Rupprecht R; Kruse K; Schulte HM
    Acta Psychiatr Scand; 1989 Jun; 79(6):597-602. PubMed ID: 2548370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine responses to growth hormone releasing hormone and corticotropin releasing hormone in early-onset Alzheimer's disease.
    Lesch KP; Ihl R; Frölich L; Rupprecht R; Müller U; Schulte HM; Maurer K
    Psychiatry Res; 1990 Aug; 33(2):107-12. PubMed ID: 2173839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pyridostigmine, corticotropin-releasing hormone and growth hormone-releasing hormone on the pituitary-adrenal axis and on growth hormone secretion in dementia.
    Murialdo G; Fonzi S; Torre F; Costelli P; Solinas G; Tosca P; Di Paolo E; Porro S; Zerbi F; Polleri A
    Neuropsychobiology; 1993; 28(4):177-83. PubMed ID: 8272199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone-releasing hormone and corticotropin-releasing hormone enhance non-rapid-eye-movement sleep after sleep deprivation.
    Schüssler P; Yassouridis A; Uhr M; Kluge M; Weikel J; Holsboer F; Steiger A
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E549-56. PubMed ID: 16912060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
    Trainer PJ; Faria M; Newell-Price J; Browne P; Kopelman P; Coy DH; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1995 Feb; 80(2):412-7. PubMed ID: 7852498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intranasal growth hormone-releasing hormone and corticotropin-releasing hormone administration on growth hormone and cortisol release: improved bioavailability by means of sodium-glycocholate.
    Pontiroli AE; Perfetti MG; Fattor B; Pozza G
    J Clin Endocrinol Metab; 1989 Apr; 68(4):821-4. PubMed ID: 2493480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid sequential intravenous administration of four hypothalamic releasing hormones as a combined anterior pituitary function test in normal subjects.
    Sheldon WR; DeBold CR; Evans WS; DeCherney GS; Jackson RV; Island DP; Thorner MO; Orth DN
    J Clin Endocrinol Metab; 1985 Apr; 60(4):623-30. PubMed ID: 2982903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.